Suppr超能文献

钠氢交换体调节因子-1 参与趋化因子受体同源二聚体 CCR5 的内化和信号转导,但不影响 CXCR4 同源二聚体或 CXCR4-CCR5 异源二聚体。

Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.

机构信息

Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 1X5, Canada.

出版信息

J Biol Chem. 2010 Nov 5;285(45):34653-64. doi: 10.1074/jbc.M110.106591. Epub 2010 Aug 26.

Abstract

Chemokine receptors are members of the G protein-coupled receptor (GPCR) family. CCR5 is also the principal co-receptor for macrophage-tropic strains of human immunodeficiency virus, type 1 (HIV-1), and efforts have been made to develop ligands to inhibit HIV-1 infection by promoting CCR5 receptor endocytosis. Given the nature of GPCRs and their propensity to form oligomers, one can consider ligand-based therapies as unselective in terms of the oligomeric composition of complexes. For example, a ligand targeting a CCR5 homomer could likely induce signal transduction on a heteromeric CCR5-CXCR4. Other avenues could therefore be explored. We identified a receptor adaptor interacting specifically with one receptor complex but not others. NHERF1, an adaptor known for its role in desensitization, internalization, and regulation of the ERK signaling cascade for several GPCRs, interacts via its PDZ2 domain with the CCR5 homodimer but not with the CXCR4-CCR5 heterodimer or CXCR4 homodimer. To further characterize this interaction, we also show that NHERF1 increases the CCR5 recruitment of arrestin2 following stimulation. NHERF1 is also involved in CCR5 internalization, as we demonstrate that co-expression of constructs bearing the PDZ2 domain can block CCR5 internalization. We also show that NHERF1 potentiates RANTES (regulated on activation normal T cell expressed and secreted)-induced ERK1/2 phosphorylation via CCR5 activation and that this activation requires NHERF1 but not arrestin2. Taken together, our results suggest that oligomeric receptor complexes can associate specifically with partners and that in this case NHERF1 could represent an interesting new target for the regulation of CCR5 internalization and potentially HIV infection.

摘要

趋化因子受体是 G 蛋白偶联受体 (GPCR) 家族的成员。CCR5 也是人类免疫缺陷病毒 1 型 (HIV-1) 中巨噬细胞嗜性株的主要共受体,人们已经努力开发能够通过促进 CCR5 受体内化来抑制 HIV-1 感染的配体。鉴于 GPCR 的性质及其形成寡聚体的倾向,可以认为配体基疗法在复合物的寡聚体组成方面是非选择性的。例如,针对 CCR5 同源二聚体的配体可能会在异源 CCR5-CXCR4 上诱导信号转导。因此,可以探索其他途径。我们发现一种受体衔接蛋白与一种受体复合物特异性相互作用,但与其他复合物不相互作用。NHERF1 是一种已知在几种 GPCR 中发挥脱敏、内化和调节 ERK 信号级联作用的衔接蛋白,通过其 PDZ2 结构域与 CCR5 同源二聚体相互作用,但不与 CXCR4-CCR5 异源二聚体或 CXCR4 同源二聚体相互作用。为了进一步表征这种相互作用,我们还表明 NHERF1 增加了 CCR5 募集的 ARRESTIN2 刺激后。NHERF1 也参与 CCR5 的内化,因为我们证明表达含有 PDZ2 结构域的构建体可以阻断 CCR5 的内化。我们还表明,NHERF1 通过 CCR5 激活增强 RANTES(激活正常 T 细胞表达和分泌调节)诱导的 ERK1/2 磷酸化,并且这种激活需要 NHERF1 而不是 ARRESTIN2。总之,我们的结果表明,寡聚体受体复合物可以与特定的伙伴结合,在这种情况下,NHERF1 可能代表了调节 CCR5 内化和潜在 HIV 感染的一个有趣的新靶点。

相似文献

引用本文的文献

2
The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells.β2-肾上腺素能受体与人癌细胞中的 CXCR4 多聚体相关联。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2304897121. doi: 10.1073/pnas.2304897121. Epub 2024 Mar 28.

本文引用的文献

8
Identification of a postendocytic sorting sequence in CCR5.CCR5中内吞后分选序列的鉴定。
Mol Pharmacol. 2007 Dec;72(6):1497-507. doi: 10.1124/mol.107.038422. Epub 2007 Sep 12.
9
HIV entry inhibitors.HIV 进入抑制剂
Lancet. 2007 Jul 7;370(9581):81-8. doi: 10.1016/S0140-6736(07)61052-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验